{"title": "PPT - VACUNAS Y VACUNACI\u00d3N EN BOVINOS PowerPoint Presentation, free download - ID:4892132", "author": "Emlyn", "url": "https://www.slideserve.com/emlyn/vacunas-y-vacunaci-n-en-bovinos", "hostname": "slideserve.com", "description": "VACUNAS Y VACUNACI\u00d3N EN BOVINOS. EN LA REP\u00daBLICA ARGENTINA. M\u00e9d. Vet. Enrique M. TRABATTONI Facultad de Ciencias Veterinarias, Universidad Nacional del Litoral Colegio M\u00e9dicos Veterinarios Pcia. de Santa Fe. VACUNAS Y VACUNACI\u00d3N EN BOVINOS. 1. ACTO M\u00c9DICO. FRACASO DEL RODEO DE CR\u00cdA", "sitename": "SlideServe", "date": "2014-09-28", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "750 likes | 1.35k Views\nVACUNAS Y VACUNACI\u00d3N EN BOVINOS. EN LA REP\u00daBLICA ARGENTINA. M\u00e9d. Vet. Enrique M. TRABATTONI Facultad de Ciencias Veterinarias, Universidad Nacional del Litoral Colegio M\u00e9dicos Veterinarios Pcia. de Santa Fe. VACUNAS Y VACUNACI\u00d3N EN BOVINOS. 1. ACTO M\u00c9DICO. FRACASO DEL RODEO DE CR\u00cdA\nE N D\n[VACUNAS Y VACUNACI\u00d3N EN BOVINOS](https://image2.slideserve.com/4892132/vacunas-y-vacunaci-n-en-bovinos-l.jpg) EN LA REP\u00daBLICA ARGENTINA M\u00e9d. Vet. Enrique M. TRABATTONI Facultad de Ciencias Veterinarias, Universidad Nacional del Litoral Colegio M\u00e9dicos Veterinarios Pcia. de Santa Fe [VACUNAS Y VACUNACI\u00d3N EN BOVINOS](https://image2.slideserve.com/4892132/slide2-l.jpg) 1 ACTO M\u00c9DICO FRACASO DEL RODEO DE CR\u00cdA PLAN SANITARIO EN RODEOS DE CR\u00cdA INSERCI\u00d3N DEL ACTO M\u00c9DICO DENTRO DE UN SSP 2 3 trabajos EVALUACI\u00d3N TRANSFERENCIA DE TECNOLOG\u00cdA VACUNAS PARA BOVINOS DISPONIBLES EN R.A. A\u00d1O 2003 3 \u00bfPOR QU\u00c9? Necesidad de impacto tecnol\u00f3gico A trav\u00e9s del corresponsable sanitario Dentro de un SSP [\u00cdNDICE](https://image2.slideserve.com/4892132/slide3-l.jpg) \u2022 Generalidades de vacunaci\u00f3n y vacunas \u2022 El corresponsable sanitario en los sistemas sanitarios productivos (SSP) \u2022 Vacunas para bovinos disponibles en la Rep\u00fablica Argentina \u2022 Conclusiones [VACUNACI\u00d3N](https://image2.slideserve.com/4892132/slide5-l.jpg) Es un acto m\u00e9dico m\u00e1s, dentro de la profilaxis de una enfermedad, por el cual se decide administrar un ant\u00edgeno (derivado de un agente infeccioso), con el objetivo de desarrollar una respuesta inmune espec\u00edfica, protectora y duradera. [CLASIFICACI\u00d3N (1)](https://image2.slideserve.com/4892132/clasificaci-n-1-l.jpg) CLASIFICACI\u00d3N DE VACUNAS \u2022 V\u00cdRICAS \u2022 BACTERIANAS \u2022 PARASITARIAS Seg\u00fan TIPO DE ANT\u00cdGENO [CLASIFICACI\u00d3N DE VACUNAS](https://image2.slideserve.com/4892132/slide7-l.jpg) Seg\u00fan VARIEDAD DE ANT\u00cdGENO \u2022 MONOVALENTES \u2022 Rabia \u2022 Brucelosis \u2022 POLIVALENTES \u2022 Aftosa \u2022 Leptospirosis \u2022 MIXTAS \u2022 BVD + IBR + Leptospirosis + Campylobacteriosis \u2022 IBR + Moraxella bovis + Branhamella ovis [CLASIFICACI\u00d3N DE VACUNAS](https://image2.slideserve.com/4892132/slide8-l.jpg) Seg\u00fan ESTADO BIOL\u00d3GICO DEL ANT\u00cdGENO \u2022 Vacunas a microorganismos VIVOS \u2022 VIRULENTOS \u2022 ATENUADOS O MODIFICADOS \u2022 Vacunas a microorganismos MUERTOS O INACTIVADOS [CLASIFICACI\u00d3N DE VACUNAS](https://image2.slideserve.com/4892132/slide9-l.jpg) M.O. MUERTOS M.O. VIVOS \u2022 MEJOR RESPUESTA INMUNE \u2022 Se requieren POCAS DOSIS \u2022 NO NECESITAN ADYUVANTES \u2022 MENOR PROBABILIDAD DE HIPERSENSIBILIDAD \u2022 Inducen PRODUCCI\u00d3N DE INTERFER\u00d3N \u2022 RELATIVAMENTE M\u00c1S BARATAS \u2022 ESTABLES EN ALMACENAMIENTO \u2022 POCO PROBABLE QUE CAUSEN ENFERMEDAD POR VIRULENCIA RESIDUAL \u2022 POCO PROBABLE SU CONTAMINACI\u00d3N [VACUNA \u201cIDEAL\u201d](https://image2.slideserve.com/4892132/slide10-l.jpg) \u2022 Deber\u00e1 conseguir una RESPUESTA INMUNE \u2022 ESPEC\u00cdFICA \u2022 PROTECTORA \u2022 R\u00c1PIDA \u2022 DURADERA \u2022 SIN EFECTOS COLATERALES \u2022 Deber\u00e1 ser \u2022 BARATA \u2022 ESTABLE \u2022 F\u00c1CIL DE ADMINISTRAR [\u00bfCU\u00c1L ES LA VACUNA QUE MEJOR ANDA?](https://image2.slideserve.com/4892132/slide11-l.jpg) \u2022 ESTERILIDAD \u2022 INOCUIDAD \u2022 LIBRE DE M.O. EXTRA\u00d1OS \u2022 CONFIRMACI\u00d3N M.O. \u2022 Identidad \u2022 Concentraci\u00f3n SEGURIDAD CONTROLES O PRUEBAS \u201cEstatales\u201d o \u201cinternacionales\u201d POTENCIA \u2022 DESAF\u00cdO POST-VACUNAL [PROTEGIDA](https://image2.slideserve.com/4892132/slide12-l.jpg) RESPUESTA EXCELENTE FRACASO FACTORES IMPOSIBILIDAD GEN\u00c9TICA CAPAZ DE RESPONDER ANIMAL RESPUESTA DE LA POBLACI\u00d3N [CAPAZ DE RESPONDER](https://image2.slideserve.com/4892132/slide13-l.jpg) FALLAS DEL RESPONSABLE DE LA VACUNACI\u00d3N FALLAS DE LA VACUNA FALLAS DE ANIMAL RESPUESTA DE LA POBLACI\u00d3N [FALLA DE LAVACUNA](https://image2.slideserve.com/4892132/slide14-l.jpg) Vacuna eficaz \u2022 Falla de conservaci\u00f3n \u2022 Vencimiento. Vacuna ineficaz \u2022 Cepa inadecuada \u2022 Cepa adecuada: \u2022 Escasa potencia \u2022 Virulencia residual \u2022 Contaminaci\u00f3n e impurezas. [FALLA DE LARESPUESTA INMUNE DEL ANIMAL](https://image2.slideserve.com/4892132/slide15-l.jpg) Inmunidad pasiva calostral. Infecci\u00f3n en faz negativa en la vacunaci\u00f3n. Enfermedad \u2022 En incubaci\u00f3n \u2022 Declarada. Quiebre de inmunidad por superinfecci\u00f3n. Stress \u2022 Clima \u2022 Debilidad \u2022 Fatiga. Traumatismos \u2022 Ba\u00f1o \u2022 Descole \u2022 Castraci\u00f3n \u2022 Destete. Estado nutricional. [FALLA DEL RESPONSABLE DE LA VACUNACI\u00d3N](https://image2.slideserve.com/4892132/slide16-l.jpg) T\u00e9cnica de aplicaci\u00f3n incorrecta \u2022 Limpieza y asepsia del instrumental \u2022 Manejo de la vacuna \u2022 Dosis y v\u00eda de administraci\u00f3n. Vacunas Muertas (o Inactivadas) \u2022 Conservaci\u00f3n \u2022 Insuficiente homogeneizaci\u00f3n \u2022 Frascos multidosis contaminados. Vacunas Vivas \u2022 Conservaci\u00f3n \u2022 Tiempo desde resuspensi\u00f3n al uso \u2022 Diluyente inadecuado \u2022 Frascos multidosis \u2022 Desinfectante en instrumental \u2022 Antibi\u00f3tico. \u00cdndice [EL CORRESPONSABLE SANITARIO EN LOS SISTEMAS SANITARIOS](https://image2.slideserve.com/4892132/slide17-l.jpg) PRODUCTIVOS (SSP) \u00cdndice [ARGENTINA](https://image2.slideserve.com/4892132/slide18-l.jpg) VACAS21,092 millones TOROS 1,1 millones TOTAL53 millones(por vacunaci\u00f3n antiaftosa=55) PRODUCCI\u00d3N ANUAL =13,233 millones terneros 63% sobre total de vacas (48-71) [ 1.600.000 Vacas](https://image2.slideserve.com/4892132/slide19-l.jpg) 50 % 5.270.000 Vacas 4 mill 48 % 800.000 Terneros 12 mill 2.540.000 Terneros 1.894.000 Vacas 32 mill 65 % 5 mill 1.144.000 Terneros 11.845.000 Vacas 71 % 490.000 Vacas 8.450.000 Terneros 59 % 1 mill 287.000 Terneros Vacas: 21.092.000 Terneros: 13.233.000 T.E.: 24,5 ARGENTINA Fuente: Ing. Daniel Rearte-Coordinador Programa Nacional de Investigaci\u00f3n Carne y Leche-INTA [21 millones+1,1 millones](https://image2.slideserve.com/4892132/slide20-l.jpg) VACAS TOROS Aborto Parto Prematuro Mortalidad Embrionaria CAUSAS InfecciosasNo infecciosas \u201cPat\u00f3genos de la Reproducci\u00f3n\u201d TACTO \u00bfREAL?\u00bfIDEAL? 26 % 74 % 84 % PRE\u00d1ADA VAC\u00cdA Anestro Post-parto (Subnutrici\u00f3n) -6 % -10 % PARTO Muerte Neonatal Diarrea Neumon\u00eda Muerte Recr\u00eda -5 % -3 % 63 % 76 % DESTETE [16 millones de terneros destetados](https://image2.slideserve.com/4892132/slide21-l.jpg) Ideal 13,2 millones de terneros destetados Real DESTETE 63 % 76 % \u00bfDiferencia 3 millones de terneros? [OBJETIVO DE UN RODEO DE CR\u00cdA](https://image2.slideserve.com/4892132/slide22-l.jpg) PRODUCIR LA MAYOR CANTIDAD DE TERNEROS A\u00d1O A A\u00d1O Por lo tanto: \u2022 PRE\u00d1AR \u2022 DESTETAR SANIDAD NUTRICI\u00d3N PAT\u00d3GENOS DE LA REPRODUCCI\u00d3N ANESTRO POST-PARTO PRINCIPALES CAUSAS DE \u201cFRACASO\u201d EN RODEO DE CR\u00cdA [SANIDAD](https://image2.slideserve.com/4892132/slide23-l.jpg) NUTRICI\u00d3N RODEO LIBRE DE BRUCELOSIS Y TUBERCULOSIS ADAPTAR LOS M\u00c1XIMOS REQUERIMIENTOS DE LA VACA A LA OFERTA DE PASTO HEMBRAS \u2022 Diagn\u00f3stico de pre\u00f1ez \u2022 Estudio del s\u00edndrome de la vaca vac\u00eda \u2022 Profilaxis vacunal de enfermedades de la reproducci\u00f3n \u2022 Profilaxis vacunal de enfermedades del reci\u00e9n nacido (calostrado) MANEJO DE LA CARGA ANIMAL \u201cALIMENTACI\u00d3N PREFERENCIAL\u201d MACHOS ESTACIONAR EL RODEO 3 \u2013 4 MESES \u2022 Examen de aptitud reproductiva \u2022 Examen f\u00edsico \u2022 Examen sanitario trichomoniasis /campylobacteriosis \u2022 Prueba de capacidad de servicio \u2022 Profilaxis vacunal de enfermedades de la reproducci\u00f3n DESTETE PRECOZ [OBJETIVO DE UN RODEO DE CR\u00cdA](https://image2.slideserve.com/4892132/slide24-l.jpg) 47 % ESTACIONAN SERVICIO CUENCA DEL SALADO1 (Buenos Aires) 5 millones de bovinos 18.600 productores 49 %CONTROLAN TOROS 37 %DIAGNOSTICAN PRE\u00d1EZ 1- Campero, C.M. V Congreso Argentino de Reproducci\u00f3n Animal (2000). [CAMPO DE CR\u00cdA 1.200 has.](https://image2.slideserve.com/4892132/campo-de-cr-a-1-200-has-l.jpg) + + = [VACA: 1.0](https://image2.slideserve.com/4892132/slide26-l.jpg) TORO: 1.4 \u201cCAMPOS\u201d 0.7 PORCENTAJE DE TOROS 60% 75 - 85% 90 % PORCENTAJE DE PRE\u00d1EZ TACTO 60 d\u00edas 0.3 0.4 DESTETE ANTICIPADO DESTETE PRECOZ DESTETE \u201cNATURAL\u201d [RICOBENDAZOL (c/60 d\u00edas)](https://image2.slideserve.com/4892132/slide27-l.jpg) COBRE VAQUILLONA DESTETE MANCHA BRUCELOSIS PRESERVICIO CARBUNCLO IBR o IQ BVD CU\u00c1DRUPLE NACIMIENTO D\u00eda \u201c0\u201d 1/9 IBR BVD IBR BVD CU\u00c1DRUPLE 14 5 7 22 23 6 5 18 23 14 Se\u00f1al Castraci\u00f3n Doramectina Curabichera IVERMECTINA L.A. COBRE IVERMECTINA L.A. CARAVANA ADE - SELENIO F\u00d3SFORO COBRE [VACA ADULTA](https://image2.slideserve.com/4892132/slide28-l.jpg) CU\u00c1DRUPLE TACTO CARBUNCLO CU\u00c1DRUPLE DESTETE CARAVANA COBRE F\u00d3SFORO SELENIO - ADE SELENIO \u2013 ADE COBRE F\u00d3SFORO MAGNESIO ZINC DESPARASITACI\u00d3N (RICOBENDAZOL) [COSTOS](https://image2.slideserve.com/4892132/slide30-l.jpg) $25 por animal [36 Med.](https://image2.slideserve.com/4892132/costos1-l.jpg) 10 Hon. COSTOS ARGENTINA 63 % (48-71) [MERCADO ARGENTINO](https://image2.slideserve.com/4892132/slide33-l.jpg) $ 23 millones BIOL\u00d3GICOS (12%) (U$S 7,7 millones) $ 194 millones (U$S 64,7 millones) 101 Millones DOSIS (SIN AFTOSA) Fuente: Juan Carlos Aba-CAPROVE ARGENTINA: Bolet\u00edn MOTIVAR Junio 2004. [MERCADO ARGENTINO](https://image2.slideserve.com/4892132/slide34-l.jpg) RESTO AFTOSA % 52 millones de cabezas $ 8,20/animal/a\u00f1o (U$S 2,73) Resto $5,46 (U$S 1,82) AFTOSA $2 (U$S 0,67) RESTO $6,20 (U$S 2,07) Biol\u00f3gicos $0,74 (U$S 0,25) [BRUCELOSIS](https://image2.slideserve.com/4892132/slide35-l.jpg) (Zoonosis) TUBERCULOSIS (Zoonosis) RABIA PARESIANTE (Zoonosis) DIARREA AFTOSA NEUMON\u00cdA LEUCOSIS REPRODUCCI\u00d3N QUERATOCONJUNTIVITIS CLOSTRIDIALES BRUCELOSIS (Zoonosis) MASTITIS MANCHA PODODERMITIS INFECCIOSA I.B.R. B.V.D GANGRENA GASEOSA CARBUNCLO (Zoonosis) ENTEROTOXEMIA LEPTOSPIROSIS (Zoonosis) HEMOGLOBINURIA DERMATOFILOSIS PAPILOMATOSIS T\u00c9TANOS CAMPYLOBACTERIOSIS TRICHOMONIASIS (Par\u00e1sito) HEPATITIS NECROSANTE MICOTOXICOSIS BOTULISMO ANAPLASMOSIS NEOSPORA (Par\u00e1sito) BABESIOSIS (Par\u00e1sito) ACTINOBACILOSIS PARATUBERCULOSIS (\u00bfZoonosis ?) LISTERIA (Zoonosis) ACTINOMICOSIS TI\u00d1A [BRUCELOSIS](https://image2.slideserve.com/4892132/slide36-l.jpg) DIARREA RABIA PARESIANTE 778.870 dosis 11.758.055 dosis 4.334.240 dosis NEUMON\u00cdA AFTOSA CLOSTRIDIALES 138.000.000 dosis 8.917.550 dosis MANCHA (base) 33.018.858 dosis QUERATOCONJUNTIVITIS REPRODUCCI\u00d3N MIXTAS Base LEPTO 9.386.880 dosis 7.597.630 dosis HEMOGLOBINURIA ENTEROTOXEMIA CARBUNCLO I.B.R. B.V.D 20.000 dosis 551.000 dosis 1.617.070 dosis 19.606.760 dosis LEPTOSPIROSIS ANAPLASMOSIS BOTULISMO T\u00c9TANOS 2.765.000 dosis 130.000 dosis 110.000 dosis 0 dosis BABESIOSIS (mixtas) 210.000 dosis CAMPYLOBACTERIOSIS 311.000 dosis DOSIS DE VACUNAS PARA BOVINOS PRODUCIDAS A\u00d1O 2003 120.000 dosis TI\u00d1A PODODERMITIS INFECCIOSA TRICHOMONIASIS Fuentes: SENASA-CAPROVE- INTA- Laboratorios productores PAPILOMATOSIS [IBR](https://image2.slideserve.com/4892132/slide37-l.jpg) BVD Campylobacter Leptospira Haemophilus Trichomonas Otros [IBR](https://image2.slideserve.com/4892132/slide38-l.jpg) BVD Campylobacter Leptospira Haemophilus Trichomonas Otros [IBR](https://image2.slideserve.com/4892132/slide39-l.jpg) BVD Campylobacter Leptospira Haemophilus Trichomonas Otros [IBR](https://image2.slideserve.com/4892132/slide40-l.jpg) BVD Campylobacter Leptospira Haemophilus Trichomonas Otros [ROTA VIRUS](https://image2.slideserve.com/4892132/slide41-l.jpg) CORONA VIRUS Escherichia coli Salmonella Otros [ROTA VIRUS](https://image2.slideserve.com/4892132/slide42-l.jpg) CORONA VIRUS Escherichia coli Salmonella Otros [PARAINFLUENZA](https://image2.slideserve.com/4892132/slide43-l.jpg) Pasteurella IBR BVD Haemophilus V.R.S.B. Moraxella bovis Otros [PARAINFLUENZA](https://image2.slideserve.com/4892132/slide44-l.jpg) Pasteurella IBR BVD Haemophilus V.R.S.B. Moraxella bovis Otros [PARAINFLUENZA](https://image2.slideserve.com/4892132/slide45-l.jpg) Pasteurella IBR BVD Haemophilus V.R.S.B. Moraxella bovis Otros [PARAINFLUENZA](https://image2.slideserve.com/4892132/slide46-l.jpg) Pasteurella IBR BVD Haemophilus V.R.S.B. Moraxella bovis Otros [MANCHA ](https://image2.slideserve.com/4892132/slide47-l.jpg) Gangrena Gaseosa ENTEROTOXEMIA HEMOGLOBINURIA T\u00c9TANOS Hepatitis Necr\u00f3tica BOTULISMO Otros [MANCHA ](https://image2.slideserve.com/4892132/slide48-l.jpg) Gangrena Gaseosa ENTEROTOXEMIA HEMOGLOBINURIA T\u00c9TANOS Hepatitis Necr\u00f3tica BOTULISMO Otros [MANCHA ](https://image2.slideserve.com/4892132/slide49-l.jpg) Gangrena Gaseosa ENTEROTOXEMIA HEMOGLOBINURIA T\u00c9TANOS Hepatitis Necr\u00f3tica BOTULISMO OTROS [IBR](https://image2.slideserve.com/4892132/slide50-l.jpg) Moraxella bovis Branhamella ovis BVD", "language": null, "image": "https://cdn2.slideserve.com/4892132/vacunas-y-vacunaci-n-en-bovinos-n.jpg", "pagetype": "article", "links": ["\\", "#", "/presentations", "/presentations", "/topics", "/updates", "/featured", "/powerpoint-templates", "/create?utm_source=slideserve&utm_medium=website&utm_campaign=presentation+creator", "/article-stories", "/online-survey", "/online-quiz", "/lead-generation", "/create?type=ebook&utm_source=slideserve&utm_medium=website&utm_campaign=ebook+creator", "https://www.slideserve.com/create?utm_source=slideserve&utm_medium=website&utm_campaign=presentation+creator", "/pro", "/upload", "/emlyn", "https://image2.slideserve.com/4892132/vacunas-y-vacunaci-n-en-bovinos-l.jpg", "https://image2.slideserve.com/4892132/slide2-l.jpg", "https://image2.slideserve.com/4892132/slide3-l.jpg", "https://image2.slideserve.com/4892132/slide4-l.jpg", "https://image2.slideserve.com/4892132/slide5-l.jpg", "https://image2.slideserve.com/4892132/clasificaci-n-1-l.jpg", "https://image2.slideserve.com/4892132/slide7-l.jpg", "https://image2.slideserve.com/4892132/slide8-l.jpg", "https://image2.slideserve.com/4892132/slide9-l.jpg", "https://image2.slideserve.com/4892132/slide10-l.jpg", "https://image2.slideserve.com/4892132/slide11-l.jpg", "https://image2.slideserve.com/4892132/slide12-l.jpg", "https://image2.slideserve.com/4892132/slide13-l.jpg", "https://image2.slideserve.com/4892132/slide14-l.jpg", "https://image2.slideserve.com/4892132/slide15-l.jpg", "https://image2.slideserve.com/4892132/slide16-l.jpg", "https://image2.slideserve.com/4892132/slide17-l.jpg", "https://image2.slideserve.com/4892132/slide18-l.jpg", "https://image2.slideserve.com/4892132/slide19-l.jpg", "https://image2.slideserve.com/4892132/slide20-l.jpg", "https://image2.slideserve.com/4892132/slide21-l.jpg", "https://image2.slideserve.com/4892132/slide22-l.jpg", "https://image2.slideserve.com/4892132/slide23-l.jpg", "https://image2.slideserve.com/4892132/slide24-l.jpg", "https://image2.slideserve.com/4892132/campo-de-cr-a-1-200-has-l.jpg", "https://image2.slideserve.com/4892132/slide26-l.jpg", "https://image2.slideserve.com/4892132/slide27-l.jpg", "https://image2.slideserve.com/4892132/slide28-l.jpg", "https://image2.slideserve.com/4892132/costos-l.jpg", "https://image2.slideserve.com/4892132/slide30-l.jpg", "https://image2.slideserve.com/4892132/costos1-l.jpg", "https://image2.slideserve.com/4892132/slide32-l.jpg", "https://image2.slideserve.com/4892132/slide33-l.jpg", "https://image2.slideserve.com/4892132/slide34-l.jpg", "https://image2.slideserve.com/4892132/slide35-l.jpg", "https://image2.slideserve.com/4892132/slide36-l.jpg", "https://image2.slideserve.com/4892132/slide37-l.jpg", "https://image2.slideserve.com/4892132/slide38-l.jpg", "https://image2.slideserve.com/4892132/slide39-l.jpg", "https://image2.slideserve.com/4892132/slide40-l.jpg", "https://image2.slideserve.com/4892132/slide41-l.jpg", "https://image2.slideserve.com/4892132/slide42-l.jpg", "https://image2.slideserve.com/4892132/slide43-l.jpg", "https://image2.slideserve.com/4892132/slide44-l.jpg", "https://image2.slideserve.com/4892132/slide45-l.jpg", "https://image2.slideserve.com/4892132/slide46-l.jpg", "https://image2.slideserve.com/4892132/slide47-l.jpg", "https://image2.slideserve.com/4892132/slide48-l.jpg", "https://image2.slideserve.com/4892132/slide49-l.jpg", "https://image2.slideserve.com/4892132/slide50-l.jpg", "/bernad/zot1028-unidade-i-1-1-melhoramento-de-bovinos-de-corte", "/louise/gen-mica-y-su-aplicaci-n-en-bovinos", "/lathrop/mycobacterium-tuberculosis-tuberculose", "/phuc/eeb", "/isolde/protocolos-de-desparasita-o-em-bovinos-at-aos-seis-meses", "/quasim/vacunas", "/astra/inmunizaciones", "/haley/vi-jornadas-sobre-vacunas-en-atenci-n-primaria", "/kareem/escuela-polit-cnica-del-ej-rcito-departamento-de-ciencias-econ-micas-administrativas-y-comercio", "/alice/efectos-adversos-de-las-vacunas-revisi-n-bibliogr-fica", "/hide/mvz-juan-jos-ocadiz-moreno-powerpoint-ppt-presentation", "/primo/melhoramento-gen-tico-de-bovinos-de-leite", "/cady/processamento-de-gr-os-para-bovinos", "/albin/leptospirosis-la-enfermedad-de-los-pantanos-y-los-roedores", "/lassie/region-de-salud-programa-de-vacunas-e-inmunizaciones", "/kesler/conhe-a-a-cadeia-produtiva-da-carne-e-couro-bovinos", "/herve/lic-mar-a-luisa-brero", "/linus-tyler/sanidad-y-manejo-sanitario-en-bovinos-para-carne", "/aladdin-reed/temario", "/felicia-reilly/erradicaci-n-de-la-malnutrici-n-infantil", "/dillon-hooper/bovinos-de-leite", "/vivien-wade/carrera-de-enfermero-profesional-enfermeria-comunitaria", "//www.slideserve.com", "//fr.slideserve.com", "/about", "/privacy", "/dmca", "https://blog.slideserve.com", "/contact", "https://www.facebook.com/SlideServe", "https://twitter.com/slideserve", "https://www.youtube.com/user/SlideServe", "https://www.pinterest.com/slideserve/"]}